10x Genomics (TXG) Treasury Shares (2018 - 2019)
10x Genomics' (TXG) quarterly Treasury Shares came in at $67.7 million in Q2 2019, little changed quarter-over-quarter from $67.7 million in Q1 2019.
Analysis
10x Genomics (TXG) Treasury Shares (2018 - 2019) Analysis & Trends
10x Genomics has disclosed Treasury Shares across 2 years of filings, most recently posting $67.7 million for Q2 2019.
- In Q2 2019, Treasury Shares changed N/A year-over-year to $67.7 million; the TTM figure through Jun 2019 stood at $67.7 million (changed N/A YoY), while the FY2018 annual figure was $67.7 million, up 13.35% from the prior year.
- Treasury Shares came in at $67.7 million for Q2 2019 at 10x Genomics, roughly flat from $67.7 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $67.7 million in Q4 2018 to a low of $65.0 million in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 75.93 Mn |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | 32.00 Mn |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | - |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | 50.00 Mn |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | 3.53 Mn |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | - |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | 30.90 Mn |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | 67.70 Mn |
| Jun 30, 2019 | 67.70 Mn |
| Mar 31, 2019 | 67.70 Mn |
| Mar 31, 2019 | 67.70 Mn |
| Dec 31, 2018 | 67.70 Mn |
| Dec 31, 2018 | 67.70 Mn |
| Sep 30, 2018 | 64.95 Mn |
| Sep 30, 2018 | 64.95 Mn |